Cerner Corporation recently missed the Zacks Consensus Estimate and that led to analysts lowering future earnings estimates. When that happens, the Zacks Rank falls, and now as a Zacks Rank #5 (Strong Sell) CERN is the Bear of the Day.
Description
Cerner Corporation is contributing to the systemic change of health and care delivery. For more than 30 years Cerner has been executing its vision to make health care safer and more efficient. Leveraging the experience of more than three decades in clinical information systems, Cerner is building on the knowledge that is in the system to support evidence-based clinical decisions, prevent medical errors and empower patients in their care. The company offers Cerner Millennium architecture, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.
Earnings History
The most recent report was a miss, but it was only 1 cent. Prior to that, there were two meets and one beat out of the last four reports. To me, that looks ok and is not enough to become a Zacks Rank #5 (Strong Sell).
Estimates Revisions
The detailed estimates page shows me that there have been a ton of negative revisions over the last 60 days. This is the reason the stock is now a Zacks Rank #5 (Strong Sell)
Estimates have moved from $2.50 to $2.43 for this year and from $2.78 to $2.62 next year. When earnings estimates move lower, so does the Zacks Rank.
Wall Street’s Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Click for details >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Cerner Corporation recently missed the Zacks Consensus Estimate and that led to analysts lowering future earnings estimates. When that happens, the Zacks Rank falls, and now as a Zacks Rank #5 (Strong Sell) CERN is the Bear of the Day.
Description
Cerner Corporation is contributing to the systemic change of health and care delivery. For more than 30 years Cerner has been executing its vision to make health care safer and more efficient. Leveraging the experience of more than three decades in clinical information systems, Cerner is building on the knowledge that is in the system to support evidence-based clinical decisions, prevent medical errors and empower patients in their care. The company offers Cerner Millennium architecture, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.
Earnings History
The most recent report was a miss, but it was only 1 cent. Prior to that, there were two meets and one beat out of the last four reports. To me, that looks ok and is not enough to become a Zacks Rank #5 (Strong Sell).
Estimates Revisions
The detailed estimates page shows me that there have been a ton of negative revisions over the last 60 days. This is the reason the stock is now a Zacks Rank #5 (Strong Sell)
Estimates have moved from $2.50 to $2.43 for this year and from $2.78 to $2.62 next year. When earnings estimates move lower, so does the Zacks Rank.
Wall Street’s Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Click for details >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>